Resistance of Fbxo22 knockout cancer cells to poly (ADP-ribose) polymerase (PARP) inhibitor

被引：0
|
作者：
Lai, Yongqiang [1 ]
Wu, Wenwen [1 ]
Liang, Weixin [2 ]
Ohta, Tomohiko [1 ]
机构：
[1] St Marianna Univ, Grad Sch Med, Translat Oncol, Kawasaki, Kanagawa, Japan
[2] Gaoming Peoples Hosp, Dept Gen Surg 1, Foshan, Guangdong, Peoples R China
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
F-box protein; Parp;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3352
引用
收藏
页码：1141 / 1141
页数：1
相关论文
共 50 条
  • [21] Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer
    Heitmann, Jana
    Geeleher, Paul
    Zuo, Zhixiang
    Weichselbaum, Ralph R.
    Vokes, Everett E.
    Fetscher, Sebastian
    Seiwert, Tanguy Y.
    ORAL ONCOLOGY, 2014, 50 (09) : 825 - 831
  • [22] Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy
    Miller, Rowan E.
    CANCER JOURNAL, 2021, 27 (06): : 506 - 510
  • [23] The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer
    Kathleen Moore
    Zhi-Yi Zhang
    Shefali Agarwal
    Howard Burris
    Manish R. Patel
    Vikram Kansra
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 497 - 503
  • [24] The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer
    Moore, Kathleen
    Zhang, Zhi-Yi
    Agarwal, Shefali
    Burris, Howard
    Patel, Manish R.
    Kansra, Vikram
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 497 - 503
  • [25] Poly (ADP-ribose) polymerase (PARP) inhibition in cancer: Potential impact in cancer stem cells and therapeutic implications
    Rizvi, Asim
    Merlin, Marine A.
    Shah, Girish M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 911
  • [26] Effect of a novel poly (ADP-ribose) polymerase (PARP) inhibitor in rodent models of local inflammation
    Mabley, J
    Virag, L
    Jagtap, P
    Szabo, E
    Prendergast, R
    Perretti, M
    Getting, S
    Szabo, C
    FASEB JOURNAL, 2001, 15 (04): : A242 - A242
  • [27] Mechanisms of resistance to poly (ADP-ribose) polymerase inhibitors in prostate cancer
    Atiq, Mohammad
    Chakraborty, Goutam
    Nandakumar, Subhiksha
    Mazzu, Ying Z.
    Stopsack, Konrad
    Yoshikawa, Yuki
    Khan, Nabeela
    Lee, Gwo-Shu Mary
    Kantoff, Philip W.
    CANCER RESEARCH, 2019, 79 (13)
  • [28] Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers
    Shieh, WM
    Amé, JC
    Wilson, MV
    Wang, ZQ
    Koh, DW
    Jacobson, MK
    Jacobson, EL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) : 30069 - 30072
  • [29] A systematic review of racial disparity in pivotal poly (ADP-ribose) polymerase (PARP) inhibitor trials
    John, Elizabeth
    Sekhon, Simranjit
    Bagchi, Arindam
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer
    Dong, Ruihong
    Ding, Ting
    Li, Zhengyu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345